MedTrace Logo

Functional Test for a Drink Powder Alone and Combined Use With a Cosmetic Apparatus

NCT05041205 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2021-09-10

No results posted yet for this study

Summary

This study is designed to observe human consuming effect of a beauty drink powder and combined use with a cosmetic apparatus. It is a randomized, double-blind, and placebo-control study. The target enrollment of subjects is 160 and 4 arms are included, a placebo control, drink powder alone, cosmetic apparatus alone, and drink powder plus cosmetic apparatus. Effects on skin dullness, skin tone unevenness, skin dryness, skin elasticity, wrinkle and fine line are evaluated. Both objective and subjective methods are used for efficacy evaluation. Data are collected at baseline, week 4, week 8, and week 12 after treatment.

Conditions

  • Beauty Drink Powder
  • Cosmetic Apparatus on Skin
  • Skin Elasticity
  • Skin Dryness
  • Skin Moisture
  • Skin Evenness
  • Skin Firmness

Interventions

DIETARY_SUPPLEMENT

Beauty drink powder

Beauty drink powder is designed as a oral beauty product to provide benefits to skin

DEVICE

Cosmetic apparatus

This device is designed to let participants to experience brighter, softer, smoother skin and an energizing facial massage. A synergestic effect when combine with beauty drink powder is expected.

Sponsors & Collaborators

  • Pharmanex

    lead INDUSTRY

Principal Investigators

  • Wenwen Gu, PhD · Shanghai China-norm Quality Technical Service Co., Ltd.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-22
Primary Completion
2021-06-21
Completion
2021-08-16

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05041205 on ClinicalTrials.gov